Tower Research Capital (TRC)’s Adamas Pharmaceuticals, Inc. ADMS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2021
Q3
Sell
-7,520
Closed -$40K 6541
2021
Q2
$40K Sell
7,520
-3,660
-33% -$19.5K ﹤0.01% 3227
2021
Q1
$54K Buy
11,180
+8,154
+269% +$39.4K ﹤0.01% 3065
2020
Q4
$13K Sell
3,026
-4,100
-58% -$17.6K ﹤0.01% 4181
2020
Q3
$29K Buy
7,126
+6,299
+762% +$25.6K ﹤0.01% 3742
2020
Q2
$2K Sell
827
-3,877
-82% -$9.38K ﹤0.01% 4563
2020
Q1
$14K Buy
+4,704
New +$14K ﹤0.01% 1899
2019
Q4
Sell
-1,007
Closed -$5K 4717
2019
Q3
$5K Buy
+1,007
New +$5K ﹤0.01% 3367
2019
Q2
Sell
-2,093
Closed -$15K 4578
2019
Q1
$15K Buy
2,093
+1,337
+177% +$9.58K ﹤0.01% 2459
2018
Q4
$6K Sell
756
-7,343
-91% -$58.3K ﹤0.01% 2847
2018
Q3
$162K Buy
+8,099
New +$162K 0.01% 1092
2018
Q2
Sell
-2,241
Closed -$54K 4268
2018
Q1
$54K Buy
+2,241
New +$54K ﹤0.01% 1640
2017
Q4
Sell
-1,483
Closed -$31K 4350
2017
Q3
$31K Sell
1,483
-4,750
-76% -$99.3K ﹤0.01% 2423
2017
Q2
$109K Buy
+6,233
New +$109K 0.01% 468
2017
Q1
Sell
-1,061
Closed -$18K 4224
2016
Q4
$18K Buy
+1,061
New +$18K ﹤0.01% 2257
2016
Q3
Sell
-100
Closed -$2K 4773
2016
Q2
$2K Sell
100
-5,077
-98% -$102K ﹤0.01% 4013
2016
Q1
$75K Buy
+5,177
New +$75K 0.01% 588
2015
Q4
Sell
-2,838
Closed -$48K 5298
2015
Q3
$48K Buy
+2,838
New +$48K ﹤0.01% 1055
2015
Q2
Sell
-730
Closed -$13K 5299
2015
Q1
$13K Sell
730
-1,253
-63% -$22.3K ﹤0.01% 2593
2014
Q4
$34K Buy
+1,983
New +$34K ﹤0.01% 1262
2014
Q3
Sell
-2,969
Closed -$54K 5071
2014
Q2
$54K Buy
+2,969
New +$54K 0.01% 1253